332 related articles for article (PubMed ID: 24695736)
1. Deficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice.
Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
J Biol Chem; 2014 May; 289(20):13821-37. PubMed ID: 24695736
[TBL] [Abstract][Full Text] [Related]
2. Lack of oncostatin M receptor β leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype.
Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
J Biol Chem; 2013 Jul; 288(30):21861-75. PubMed ID: 23760275
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice.
Komori T; Tanaka M; Furuta H; Akamizu T; Miyajima A; Morikawa Y
Diabetologia; 2015 Aug; 58(8):1868-76. PubMed ID: 25972231
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M in the development of metabolic syndrome and its potential as a novel therapeutic target.
Komori T; Morikawa Y
Anat Sci Int; 2018 Mar; 93(2):169-176. PubMed ID: 29103176
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance.
Luo P; Wang PX; Li ZZ; Zhang XJ; Jiang X; Gong J; Qin JJ; Guo J; Zhu X; Yang S; Li H
Am J Pathol; 2016 May; 186(5):1278-92. PubMed ID: 26976243
[TBL] [Abstract][Full Text] [Related]
6. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.
Elks CM; Zhao P; Grant RW; Hang H; Bailey JL; Burk DH; McNulty MA; Mynatt RL; Stephens JM
J Biol Chem; 2016 Aug; 291(33):17066-76. PubMed ID: 27325693
[TBL] [Abstract][Full Text] [Related]
7. Adipocyte Oncostatin Receptor Regulates Adipose Tissue Homeostasis and Inflammation.
Sanchez-Infantes D; Stephens JM
Front Immunol; 2020; 11():612013. PubMed ID: 33854494
[TBL] [Abstract][Full Text] [Related]
8. Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway.
Chang TC; Chiou WC; Lai WH; Huang HC; Huang YL; Liu HK; Liang YC; Huang C
Pharmacol Res; 2021 Jan; 163():105298. PubMed ID: 33220422
[TBL] [Abstract][Full Text] [Related]
9. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
[TBL] [Abstract][Full Text] [Related]
10. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
[TBL] [Abstract][Full Text] [Related]
11. Essential roles of oncostatin M receptor β signaling in renal crystal formation in mice.
Yamashita S; Komori T; Kohjimoto Y; Miyajima A; Hara I; Morikawa Y
Sci Rep; 2020 Oct; 10(1):17150. PubMed ID: 33051515
[TBL] [Abstract][Full Text] [Related]
12. Partial leptin deficiency confers resistance to diet-induced obesity in mice.
Zhao S; Li N; Zhu Y; Straub L; Zhang Z; Wang MY; Zhu Q; Kusminski CM; Elmquist JK; Scherer PE
Mol Metab; 2020 Jul; 37():100995. PubMed ID: 32289482
[TBL] [Abstract][Full Text] [Related]
13. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M Confers Neuroprotection against Ischemic Stroke.
Guo S; Li ZZ; Gong J; Xiang M; Zhang P; Zhao GN; Li M; Zheng A; Zhu X; Lei H; Minoru T; Li H
J Neurosci; 2015 Aug; 35(34):12047-62. PubMed ID: 26311783
[TBL] [Abstract][Full Text] [Related]
15. COH-SR4 reduces body weight, improves glycemic control and prevents hepatic steatosis in high fat diet-induced obese mice.
Figarola JL; Singhal P; Rahbar S; Gugiu BG; Awasthi S; Singhal SS
PLoS One; 2013; 8(12):e83801. PubMed ID: 24376752
[TBL] [Abstract][Full Text] [Related]
16. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
[TBL] [Abstract][Full Text] [Related]
17. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
[TBL] [Abstract][Full Text] [Related]
18. Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion.
de Oliveira PR; da Costa CA; de Bem GF; Cordeiro VS; Santos IB; de Carvalho LC; da Conceição EP; Lisboa PC; Ognibene DT; Sousa PJ; Martins GR; da Silva AJ; de Moura RS; Resende AC
PLoS One; 2015; 10(12):e0143721. PubMed ID: 26630290
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of T cell CD40L has minor beneficial effects on obesity-induced metabolic dysfunction.
Reiche ME; den Toom M; Willemsen L; van Os B; Gijbels MJJ; Gerdes N; Aarts SABM; Lutgens E
BMJ Open Diabetes Res Care; 2019; 7(1):e000829. PubMed ID: 31908798
[TBL] [Abstract][Full Text] [Related]
20. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
Begriche K; Lettéron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E939-51. PubMed ID: 18349116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
